Work

Investigating the structural basis of HMG-CoA reductase cofactor specificity

Year: 2020
Type: other
Abstract: The mevalonate pathway synthesizes the precursors of isoprenoids, the largest and most structurally diverse class of natural products, many of which are used as drugs for the treatment of human diseases. Catalyzing the committed and rate-limiting step of the mevalonate pathway, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase (HMGR) reduces HMG-CoA to mevalonate using two
Language: English
Open Access status: gold
OpenAlex ID: W4244747439
Cites:
Cited by:
Related to: 10